ketanserin has been researched along with ketamine in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Mana, MJ; Paul, D; Pfaus, JG; Pinel, JP | 1 |
Anuradha, K; Hota, D; Pandhi, P | 1 |
Bauer, A; Elmenhorst, D; Herzog, H; Hurlemann, R; Matusch, A; Rota Kops, E; Winz, OH; Zilles, K | 1 |
France, CP; Javors, MA; Koek, W; Li, JX; Rice, KC; Unzeitig, A | 1 |
1 trial(s) available for ketanserin and ketamine
Article | Year |
---|---|
Acute S-ketamine application does not alter cerebral [18F]altanserin binding: a pilot PET study in humans.
Topics: Adult; Algorithms; Brain; Butanols; Double-Blind Method; Excitatory Amino Acid Antagonists; Heart Rate; Humans; Image Processing, Computer-Assisted; Ketamine; Ketanserin; Male; Pilot Projects; Positron-Emission Tomography; Psychiatric Status Rating Scales | 2007 |
8 other study(ies) available for ketanserin and ketamine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Attenuation of morphine analgesia by the S2 antagonists, pirenperone and ketanserin.
Topics: Analgesia; Animals; Dose-Response Relationship, Drug; Ketamine; Ketanserin; Male; Morphine; Piperidines; Rats; Reaction Time; Receptors, Serotonin; Serotonin Antagonists | 1988 |
Investigation of central mechanism of insulin induced hypoglycemic convulsions in mice.
Topics: 5-Hydroxytryptophan; Animals; Anticonvulsants; Antihypertensive Agents; Blood Glucose; Dopamine; Dopamine Agents; Drug Interactions; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Hypoglycemia; Hypoglycemic Agents; Insulin; Ketamine; Ketanserin; Levodopa; Male; Mice; Reserpine; Seizures; Serotonin; Serotonin Antagonists; Survival Rate | 2004 |
Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.
Topics: Analgesics, Opioid; Anesthetics, Dissociative; Animals; Conditioning, Operant; Discrimination, Psychological; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fluorobenzenes; Ketamine; Ketanserin; Male; Morphine; Phencyclidine; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-1; Ritanserin; Serotonin Antagonists; Serotonin Receptor Agonists | 2009 |